FLGT

Fulgent Genetics

Healthcare Diagnostics & Research NASDAQ

About the company

Fulgent Genetics Inc is a leading technology company at the forefront of genetic testing and diagnostics. With a primary focus on providing physicians with clinically actionable information, they play a crucial role in early disease identification, genetic predisposition assessment, and improved treatment and prognosis. By leveraging the power of genetics, Fulgent Genetics offers a wide range of cutting-edge solutions to empower healthcare providers and patients. One of Fulgent Genetics' key offerings is their Genes & Panels product portfolio. This comprehensive suite of tests covers a vast array of genetic conditions, providing physicians with a comprehensive understanding of their patient's genetic makeup. These tests can identify not only specific genetic mutations associated with certain diseases but also offer insights into the overall genomic profile, allowing for a more precise diagnosis and personalized treatment plan. In addition to Genes & Panels, Fulgent Genetics provides Known Mutation testing. This approach focuses on identifying specific genetic mutations and variants known to be associated with certain diseases or conditions. By targeting these specific mutations, physicians can quickly and accurately confirm a patient's diagnoses and make informed decisions regarding treatment and management strategies. With their Genomic Testing services, Fulgent Genetics takes a comprehensive and holistic approach to genetic analysis. This type of testing examines an individual's entire genome, providing a wealth of information on their genetic makeup. It can detect various disease-causing mutations, assess an individual's predisposition to certain diseases, and offer insights into potential treatment options. Fulgent Genetics' commitment to cancer research and treatment is evident in their Hereditary Cancer testing offerings. By analyzing specific genes associated with hereditary cancers, such as breast, ovarian, colorectal, and prostate cancer, these tests help identify individuals with an increased risk of developing these conditions. This empowers both patients and healthcare professionals to take proactive measures to prevent or detect cancer earlier, leading to improved outcomes. Carrier Screening is another important aspect of Fulgent Genetics' product portfolio. This type of testing is designed to identify individuals carrying genetic mutations that may be passed on to their children. By identifying carriers of these mutations, couples can make informed decisions regarding family planning and understand the potential risks and implications for their future offspring's health. Fulgent Genetics also plays a vital role in Tumor Profiling, which involves the comprehensive analysis of the genetic makeup of tumors. This information helps healthcare providers tailor treatment plans to target specific genetic mutations driving tumor growth. By understanding the unique genomic characteristics of a tumor, physicians can prescribe personalized therapies and monitor treatment outcomes more effectively, ultimately improving patient outcomes. Sequencing Service is another important offering from Fulgent Genetics. They leverage advanced genomic sequencing technologies to analyze an individual's DNA and identify any genetic variations or mutations. This service can be used to diagnose genetic disorders, identify genetic risk factors, and assist in the development of targeted therapies. Fulgent Genetics serves a diverse range of customers, including insurance companies, hospitals, medical institutions, laboratories, government bodies, municipalities, large corporations, and individual patients. They operate primarily in the United States, where they generate the majority of their revenue. However, they also cater to international customers, expanding their impact and reach on a global scale. In summary, Fulgent Genetics Inc is a technology company specializing in genetic testing and diagnostics. By offering a comprehensive range of genetic testing solutions, they empower healthcare providers to make informed decisions, improve patient outcomes, and advance the field of personalized medicine. With their commitment to innovation and clinical expertise, Fulgent Genetics continues to play a pivotal role in the rapidly evolving field of genetics and genomics.

Website: https://www.fulgentgenetics.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1345 peers in sector

Metric FLGT Sector median Vs. industry
P/E - 20.13
EPS -2.40 USD -1.14 USD ↓ Below average
Dividend yield 0.00% 0.00%
Profit margin -23.04% 0.00% ↓ Below average
ROE -6.92% -58.89% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Fulgent Genetics?
Fulgent Genetics Inc is a leading technology company at the forefront of genetic testing and diagnostics. With a primary focus on providing physicians with clinically actionable information, they play a crucial role in early disease identification, genetic predisposition assessment, and improved treatment and prognosis. By leveraging the power of genetics, Fulgent Genetics offers a wide range of cutting-edge solutions to empower healthcare providers and patients. One of Fulgent Genetics' key offerings is their Genes & Panels product portfolio. This comprehensive suite of tests covers a vast array of genetic conditions, providing physicians with a comprehensive understanding of their patient's genetic makeup. These tests can identify not only specific genetic mutations associated with certain diseases but also offer insights into the overall genomic profile, allowing for a more precise diagnosis and personalized treatment plan. In addition to Genes & Panels, Fulgent Genetics provides Known Mutation testing. This approach focuses on identifying specific genetic mutations and variants known to be associated with certain diseases or conditions. By targeting these specific mutations, physicians can quickly and accurately confirm a patient's diagnoses and make informed decisions regarding treatment and management strategies. With their Genomic Testing services, Fulgent Genetics takes a comprehensive and holistic approach to genetic analysis. This type of testing examines an individual's entire genome, providing a wealth of information on their genetic makeup. It can detect various disease-causing mutations, assess an individual's predisposition to certain diseases, and offer insights into potential treatment options. Fulgent Genetics' commitment to cancer research and treatment is evident in their Hereditary Cancer testing offerings. By analyzing specific genes associated with hereditary cancers, such as breast, ovarian, colorectal, and prostate cancer, these tests help identify individuals with an increased risk of developing these conditions. This empowers both patients and healthcare professionals to take proactive measures to prevent or detect cancer earlier, leading to improved outcomes. Carrier Screening is another important aspect of Fulgent Genetics' product portfolio. This type of testing is designed to identify individuals carrying genetic mutations that may be passed on to their children. By identifying carriers of these mutations, couples can make informed decisions regarding family planning and understand the potential risks and implications for their future offspring's health. Fulgent Genetics also plays a vital role in Tumor Profiling, which involves the comprehensive analysis of the genetic makeup of tumors. This information helps healthcare providers tailor treatment plans to target specific genetic mutations driving tumor growth. By understanding the unique genomic characteristics of a tumor, physicians can prescribe personalized therapies and monitor treatment outcomes more effectively, ultimately improving patient outcomes. Sequencing Service is another important offering from Fulgent Genetics. They leverage advanced genomic sequencing technologies to analyze an individual's DNA and identify any genetic variations or mutations. This service can be used to diagnose genetic disorders, identify genetic risk factors, and assist in the development of targeted therapies. Fulgent Genetics serves a diverse range of customers, including insurance companies, hospitals, medical institutions, laboratories, government bodies, municipalities, large corporations, and individual patients. They operate primarily in the United States, where they generate the majority of their revenue. However, they also cater to international customers, expanding their impact and reach on a global scale. In summary, Fulgent Genetics Inc is a technology company specializing in genetic testing and diagnostics. By offering a comprehensive range of genetic testing solutions, they empower healthcare providers to make informed decisions, improve patient outcomes, and advance the field of personalized medicine. With their commitment to innovation and clinical expertise, Fulgent Genetics continues to play a pivotal role in the rapidly evolving field of genetics and genomics.
How big is Fulgent Genetics?
The market capitalization of Fulgent Genetics — the combined value of all its shares — is 513.8 M USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Fulgent Genetics pay dividends?
The dividend yield of Fulgent Genetics is 0.00% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Fulgent Genetics belong to?
Fulgent Genetics operates in the Healthcare sector, industry: Diagnostics & Research.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120